Wegovy for Weight Loss in Bangkok, Thailand – The First FDA-Approved Weekly Injection for Obesity Treatment

Looking to get Wegovy in Bangkok or find the best price for Wegovy in Thailand? At H.U.M. Clinic, we offer more than just the medication. We provide FDA-approved weight loss treatment with Wegovy, combined with expert medical guidance every step of the way. Our experienced doctors specialize in Semaglutide-based weight loss protocols, ensuring that each patient receives personalized advice, ongoing health monitoring, and professional support to help you achieve safe, sustainable, and long-term fat loss results.

What is Wegovy?

Wegovy is a brand name for Semaglutide, a GLP-1 receptor agonist developed specifically for weight management in people with overweight or obese. The medication is produced by Novo Nordisk, a global pharmaceutical company headquartered in Denmark, known for its leadership in diabetes and obesity treatments. 

Wegovy is administered as a once-weekly subcutaneous injection, conveniently delivered in a pre-filled pen device designed for self-injection at home. This makes it easy and practical for long-term use. 

The drug is FDA-approved in the United States for chronic weight management in adults with: 

• BMI ≥30 kg/m², or 

• BMI ≥27 kg/m² with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol) 

Wegovy has been studied extensively in humans through the STEP clinical trial program, which began in 2018 and continued through 2023, involving over 17,000 participants globally. These trials provided strong evidence of Wegovy’s effectiveness and safety in a wide range of populations including people with diabetes, heart disease, adolescents, and patients from East Asia including Thailand. 

With its scientific backing and ease of use, Wegovy has quickly become one of the most trusted and effective weight loss treatments available today. 

Wegovy vs. Ozempic: What’s the Difference?

If you’re comparing Wegovy and Ozempic, it’s important to know that both medications contain Semaglutide, a GLP-1 receptor agonist that helps control appetite, reduce blood sugar, and support weight loss. However, they are designed for different medical uses and dosing strategies. 

What’s the Difference?

• Wegovy is FDA-approved for chronic weight management in people with overweight or obese. It is prescribed at a higher target dose of 2.4 mg once weekly, which is optimized for significant fat loss and long-term weight control. 

• Ozempic is approved for type 2 diabetes treatment and is generally used at lower doses up to 2.0 mg once weekly to help lower blood sugar and reduce cardiovascular risk. 

What is Similar?

Despite the differences in indication and dosage, Wegovy and Ozempic share several key similarities: 

• Same active ingredient: Both contain Semaglutide 

• Same mechanism of action: Both mimic GLP-1, which helps regulate appetite and blood sugar 

• Same administration method: Both are once-weekly injectable pens 

• Same manufacturer: Developed by Novo Nordisk, a global pharma company from Denmark 

Are They Interchangeable?

Wegovy and Ozempic are not officially interchangeable, but they can be used off-label for similar outcomes especially in weight management. However, because the dosages and approved indications differ, any substitution must be done under medical supervision. 

If you’re considering using Ozempic for weight loss or switching between the two, our doctors at H.U.M. Clinic Bangkok can guide you through the safe and effective dosing strategy that fits your health status and goals. 

How Wegovy Works?

Wegovy mimics glucagon-like peptide-1 (GLP-1), a hormone that regulates appetite and glucose metabolism. As a GLP-1 analog, Wegovy: 

• Reduces hunger and appetite 

• Slows gastric emptying 

• Improves blood sugar control 

• Enhances satiety after meals 

The result is a significant reduction in caloric intake, leading to substantial weight loss over time.

How Effective Is Wegovy?

Wegovy’s effectiveness has been proven in several key clinical trials, most notably the STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program. 

• STEP 1 Trial (2021, New England Journal of Medicine) 

• Participants: 1,961 adults without diabetes 

• Results: Average weight loss of 14.9% from baseline 

• Nearly 70% lost ≥10% of their starting weight 

• Over 30% lost ≥20% of their starting weight 

• STEP 3 Trial (2021) combined Semaglutide with intensive behavioral therapy, yielding even higher results with average weight loss of 16% from baseline. 

• Weight loss with Wegovy often plateaus after 6–12 months and remains stable with ongoing treatment.

Proven Benefits of Wegovy: Backed by the STEP Clinical Trials

Wegovy (semaglutide 2.4 mg) has been studied in one of the most comprehensive obesity research programs ever — the STEP trial series. These global studies involved thousands of people of different ages, ethnicities, and health conditions. The results show Wegovy is not only effective for weight loss but also offers major health benefits for people with diabetes, pre-diabetes, heart issues, and even adolescents. 

Key Findings from STEP Trials: 

• STEP 1 – People without diabetes lost an average of 15% of their body weight over 68 weeks using Wegovy plus healthy lifestyle support. 

• STEP 2 – Adults with type 2 diabetes lost up to 10% of their weight, showing Wegovy’s strong effect even in insulin-resistant conditions. 

• STEP 3 – Adding intensive behavioral therapy (IBT) led to even more success: average weight loss reached 16%. 

• STEP 4 & 5 – Wegovy helped patients maintain weight loss over the long term, with lasting health improvements. 

• STEP 6 & 11 – Clinical trials conducted in Thailand, Korea, and East Asia confirmed Wegovy works just as effectively in Asian populations. 

• STEP 7 – Studied Wegovy in a global population including China, Brazil, and Korea, reinforcing its broad international benefit. 

• STEP 8 – Compared Wegovy with liraglutide (Saxenda) and showed that Wegovy led to greater weight loss with fewer injections (once weekly vs. daily). 

• STEP 9 – Explored Wegovy’s potential to help with knee osteoarthritis in obese patients. 

• STEP 10 – Showed Wegovy helped reverse pre-diabetes in many participants, lowering long-term diabetes risk.

Additional Studies: 

• STEP UP / T2D – Tested a higher dose (7.2 mg) of Semaglutide for patients with type 2 diabetes, showing further weight and glucose control benefits. 

• STEP TEENS – Wegovy was tested in adolescents aged 12–17 with obesity. Results showed similar 15–16% weight loss, with a safety profile similar to adults. 

• SELECT Trial – Aimed to assess Wegovy’s effect on heart health (CV outcomes). Early data shows reduced heart disease risk in overweight adults. 

• STEP HFpEF & HFpEF DM – Focused on people with heart failure with preserved ejection fraction, with and without diabetes. Wegovy improved both weight and heart-related symptoms, offering new hope for complex patients. 

In summary, Wegovy is not just for losing weight, it’s proven to help improve blood sugar, reverse pre-diabetes, improve heart function, and support adolescents and patients with chronic diseases. With over a dozen high-quality studies, it’s one of the most evidence-based weight loss treatments available today. 

Is Wegovy Right for Me?

What Are the Indications for Wegovy? 

Wegovy is approved for: 

• Adults with BMI ≥30 kg/m² 

• Adults with BMI ≥27 kg/m² and at least one weight-related condition (e.g., type 2 diabetes, hypertension, dyslipidemia) 

What Are the Contraindications for Wegovy? 

Do not use Wegovy if you have: 

• History of medullary thyroid carcinoma or MEN2 syndrome 

• Severe gastrointestinal disease 

• Pregnancy or breastfeeding 

• Hypersensitivity to Semaglutide or any components of the formulation 

A thorough doctor consultation at H.U.M. Clinic is required before prescribing Wegovy.

What Are the Side Effects of Wegovy?

Common side effects include: 

• Nausea 
• Vomiting 
• Diarrhea or constipation 
• Headache 
• Fatigue
• Injection site reactions

Most side effects improve as your body adjusts to the medication. 

How Can I Manage Side Effects from Wegovy?

• Start with a low dose and gradually titrate as per doctor’s instructions 

• Avoid greasy or heavy meals during the first few weeks 

• Stay hydrated 

• Report any serious symptoms (like persistent vomiting or abdominal pain) to your doctor immediately 

How to Titrate and Adjust Your Wegovy Dose

Proper dose titration is essential to maximize weight loss results while minimizing side effects from Wegovy (Semaglutide). At H.U.M. Clinic, our medical team provides personalized dose adjustment plans tailored to each individual’s tolerance, goals, and health condition.

Recommended Titration Schedule

The standard titration protocol, based on clinical trials and FDA guidelines, gradually increases the dose over 16 weeks to reach the target maintenance dose of 2.4 mg once weekly: 

Week	Dose (Semaglutide)
1–4	0.25 mg once weekly
5–8	0.5 mg once weekly
9–12	1.0 mg once weekly
13–16	1.7 mg once weekly
Week 17+	2.4 mg once weekly (maintenance dose)

This gradual titration helps your body adjust to the medication and significantly reduces the risk of gastrointestinal side effects.

Individualized Adjustment

Some patients may need a slower titration pace or may temporarily pause dose escalation if side effects occur. At H.U.M. Clinic, we monitor your progress closely and adjust your Wegovy dose based on: 

• Side effect tolerance 

• Weight loss response 

• Blood sugar or blood pressure changes 

• Lab test results (as needed) 

We ensure that you are never left on your own, every dose decision is guided by our doctors. 

Steps to Get Wegovy at H.U.M. Clinic

1. Book a consultation with one of our medical doctors 

2. Receive a health screening and body composition check 

3. Assess suitability for Wegovy 

4. Start with weekly injections, guided and monitored by our expert team 

5. Follow-up monthly with health tracking and progress review

At H.U.M. Clinic, we are committed to transparent, honest pricing for all our treatments. If you’re looking for Wegovy in Bangkok, here’s a clear breakdown of what you can expect when starting treatment with us: 

•  Initial doctor consultation + body composition analysis: 1,500 THB 
  Includes medical evaluation, personalized weight loss planning, and full body composition assessment. 

•  Optional blood tests: Performed only when medically indicated; prices vary depending on individual needs. 

• Wegovy medication starts at 9,900 THB per month 
  Includes the Wegovy injection pen, cold-chain handling, and doctor-supervised treatment. 

• Shipping with temperature control available for clients across Thailand. 

Note: In many private hospitals, the price of Wegovy and its related services may be significantly higher than at our clinic. We encourage all clients to compare prices with nearby hospitals and see the value and personalized care they receive at H.U.M. Clinic. 

What Are the Other Weight Loss Options Available at H.U.M. Clinic?

In addition to Wegovy, we offer: 

• Tirzepatide (Mounjaro, Zepbound) 

• Testosterone optimization (TRT) programs 

• Peptide weight loss programs 

• Fat-burning injections and IV drips 

• Custom nutrition and fitness support 

Every program is tailored to your unique body and goals.

Benefits You Get When Starting Wegovy at H.U.M. Clinic

• ✅ Body composition analysis and monthly progress tracking 

• ✅ Comprehensive health assessment and doctor oversight 

• ✅ Good price, no hidden fees 

• ✅ Authorized supplier, genuine product only 

• ✅ Cold chain shipping with temperature control 

• ✅ Doctor-guided support every step of the way

Frequently Asked Questions (FAQ)